Clinical Trials Browser

Phase 2/3 × Advanced Non-small Cell Lung Cancer × rofecoxib × Clear all

NCT00385606 2023-03-23

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

Phase 2/3 Completed

Advanced Non-small Cell Lung Cancer